US News & World Report
August 20, 2019
DURING A ROUTINE physical in 2018, Matthew Farley of State College, Pennsylvania, was offered the opportunity to have his genome sequenced. As part of a research effort by his health system, Geisinger, he would learn of any disease-related gene mutations that were "actionable," meaning he'd be able to take steps to...